Codexis, Inc. (CDXS)
NASDAQ·Healthcare·Biotechnology
$2.78
+4.91%
Mkt Cap $240.80M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | $35.83M | $38.91M | +8.61% | $0.01 | $0.11 | +1000.00% | — | — |
| Q4 2025 Nov 6, 2025 | $35.83M | $8.60M | -76.00% | -$0.15 | -$0.22 | -46.67% | — | — |
| Q3 2025 Aug 13, 2025 | $19.48M | $15.33M | -21.31% | -$0.17 | -$0.16 | +5.88% | — | — |
| Q2 2025 May 14, 2025 | $9.66M | $7.54M | -21.94% | -$0.20 | -$0.25 | -25.00% | — | — |
| Q1 2025 Feb 27, 2025 | $27.41M | $21.46M | -21.71% | -$0.04 | -$0.13 | -225.00% | — | — |
| Q4 2024 Oct 31, 2024 | $27.41M | $12.83M | -53.18% | -$0.25 | -$0.29 | -16.00% | — | — |
| Q3 2024 Aug 8, 2024 | $7.82M | $7.98M | +2.03% | -$0.26 | -$0.32 | -23.08% | — | — |
| Q2 2024 May 2, 2024 | $13.66M | $17.07M | +24.99% | -$0.17 | -$0.16 | +5.88% | — | — |
| Q1 2024 Feb 28, 2024 | $19.90M | $26.56M | +33.47% | -$0.16 | $0.02 | +112.50% | — | — |
| Q4 2023 Nov 2, 2023 | $10.03M | $9.28M | -7.51% | -$0.32 | -$0.26 | +18.75% | — | — |
| Q3 2023 Aug 3, 2023 | $21.08M | $21.32M | +1.15% | -$0.21 | -$0.17 | +19.05% | — | — |
| Q2 2023 May 4, 2023 | $14.09M | $12.98M | -7.86% | -$0.29 | -$0.34 | -17.24% | — | — |
| Q1 2023 Feb 23, 2023 | $28.93M | $30.38M | +4.99% | -$0.23 | -$0.19 | +17.39% | — | — |
| Q4 2022 Nov 3, 2022 | $30.94M | $34.47M | +11.41% | -$0.18 | -$0.15 | +16.67% | — | — |
| Q3 2022 Aug 4, 2022 | $38.11M | $38.41M | +0.79% | -$0.14 | -$0.04 | +71.43% | — | — |
| Q2 2022 May 5, 2022 | $28.59M | $35.34M | +23.62% | -$0.18 | -$0.13 | +27.78% | — | — |
| Q1 2022 Feb 24, 2022 | $23.20M | $24.50M | +5.59% | -$0.18 | -$0.16 | +11.11% | — | — |
| Q4 2021 Nov 4, 2021 | $28.50M | $36.77M | +29.01% | -$0.09 | $0.03 | +133.33% | — | — |
| Q3 2021 Aug 5, 2021 | $18.34M | $25.45M | +38.78% | -$0.17 | -$0.07 | +58.82% | — | — |
| Q2 2021 May 6, 2021 | $23.44M | $18.03M | -23.08% | -$0.20 | -$0.14 | +30.00% | — | — |